跳至主要内容
临床试验/IRCT20191022045195N1
IRCT20191022045195N1招募中3 期

Comparative evaluation of triple therapy with high dose amoxicillin versus bismuth-based therapy in second-line therapy for eradication of helicobacter pylori infection in children

Qazvin University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 18 years(—)
性别
All

入选标准

  • Children with Helicobacter pylori infection who are known to be resistant to the first stage of eradication

排除标准

  • Patients who have had a positive history of taking drugs such as antibiotics during the last 4 weeks,  Bismuth, proton pump inhibitor, histamine receptor antagonist 2 or non-steroidal anti-inflammatory drug are excluded

研究者

相似试验

Comparative evaluation of triple therapy with high... | 临床试验